---

---

tags : Approval    source : Www.biospace.com   

save search

---

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
Published: 2024-04-19 (Just crawled : 14:00) - biospace.com/
SBFM | $2.1 -36.75% 6.1M |

Professional, Scientific, and T...

| Email alert Add to watchlist
pharma biosimilar health approval for canada

---

Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| 0.12% | O: 0.12% H: 0.0% C: 0.0%
fda biosimilar approval for stelara

---

Terran Biosciences Granted US Patent for the World’s First New Forms of MDMA, Potentially Clearing the Path to a Future 505(b)(2) Approval
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
FNCTF | News | $11.0354 320 |

Communications

| Email alert Add to watchlist
first patent granted approval for

---

Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
TARO | $42.14 -0.12% 2.3K |

Health Technology

| 0.48% | O: 0.19% H: 0.28% C: 0.0%
approval for meeting

---

Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
Published: 2024-04-11 (Crawled : 17:00) - biospace.com/
KPRX | $0.51 6.8K |

Manufacturing

| -14.26% | O: 3.23% H: 0.16% C: -1.79%
granted approval pharmaceuticals research for grant trial foundation study

---

Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
VVOS | $2.66 4.8K |

Health Technology

| -12.21% | O: -0.33% H: 13.91% C: -8.77%
approval care for medical

---

ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
PFE A | $25.44 0.2% 4.4M |

Health Technology

| -4.65% | O: -0.39% H: 0.0% C: 0.0%
fda approval for hiv living

---

Basilea Wins FDA Approval for Antibiotic Ending 15-Year Regulatory Quest
Published: 2024-04-04 (Crawled : 15:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -8.12% | O: -1.51% H: 0.0% C: 0.0%
fda approval

---

European Commission Expands Approval of Bristol Myers Squibb’s Reblozyl® (luspatercept) to Include First-Line Treatment of Transfusion-Dependent Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (LR-MDS)
Published: 2024-04-03 (Crawled : 08:00) - biospace.com/
BMY | $48.295 -0.01% 920K |

Health Technology

| -8.42% | O: -0.08% H: 0.3% C: -0.99%
reblozyl anemia approval treatment

---

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder
Published: 2024-04-02 (Crawled : 23:00) - biospace.com/
VNDA | $5.095 2.51% 300K |

Health Technology

| 27.18% | O: -2.43% H: 0.0% C: -2.74%
fanapt fda approval treatment

---

Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
ABT | News | $107.145 1.78% 1.3M |

Health Technology

| -5.08% | O: -0.18% H: 0.47% C: 0.12%
fda device approval heart

---

AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02 (Crawled : 13:30) - biospace.com/
PRGO | $30.16 0.74% 97K |

Health Technology

| -6.45% | O: -1.09% H: 0.13% C: -1.39%
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -8.13% | O: -0.77% H: 0.8% C: 0.74%
ABT | News | $107.145 1.78% 1.3M |

Health Technology

| -5.08% | O: -0.18% H: 0.47% C: 0.12%
SNY | News | $46.135 1.64% 270K |

Health Technology

| -6.67% | O: -1.14% H: 0.02% C: -1.06%
approval astrazeneca

---

Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
Published: 2024-03-26 (Crawled : 18:00) - biospace.com/
TAK | News | $13.235 0.57% 100K |

Health Technology

| -7.07% | O: 1.84% H: 0.24% C: -0.14%
adzynma japan takeda approval injection

---

Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
Published: 2024-03-25 (Crawled : 23:00) - biospace.com/
AMRX | $5.36 62K |

Health Technology

| -11.7% | O: 0.0% H: 0.33% C: -2.64%
fda approval

---

Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to Drug
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -6.83% | O: -0.03% H: 0.0% C: 0.0%
fda drug approval hypertension

---

Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to...
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M |

Health Technology

| -6.83% | O: -0.03% H: 0.0% C: 0.0%
fda approval hypertension

---

Takeda Announces U.S. FDA Approval of Supplemental New Drug Application (sNDA) for ICLUSIG® (ponatinib) in Adult Patients with Newly Diagnosed Ph+ ALL
Published: 2024-03-19 (Crawled : 17:00) - biospace.com/
TAK | News | $13.235 0.57% 100K |

Health Technology

| -9.68% | O: -0.07% H: 0.0% C: -0.96%
iclusig fda drug takeda approval application

---

Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB®
Published: 2024-03-18 (Crawled : 14:00) - biospace.com/
SCLX | $0.9249 2.77% 160K |

| -14.6% | O: -0.73% H: 3.31% C: 0.74%
elyxyb drug patent company health approval review canada submission

---

Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
Published: 2024-03-14 (Crawled : 11:00) - biospace.com/
BSX | $67.725 0.45% 1.6M |

Health Technology

| 2.09% | O: -0.15% H: 1.47% C: 1.4%
AXNX | $67.11 0.09% 45K |

Health Technology

| -0.74% | O: -0.06% H: 0.35% C: 0.07%
axonics approval system

---

Mirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
MIRM | $23.64 0.3% 35K |

Health Technology

| -14.23% | O: 1.49% H: 2.98% C: -0.43%
fda pruritus approval treatment livmarli

---

Gainers vs Losers

83%

17%

Top 10 Gainers

AGBA | News | $1.37 242.5% 76M |

Finance

EGOX | $0.0835 131.94% 160M |

ZCMD | $2.18 50.35% 24M |

Commercial Services

CHRO | $1.73 41.22% 46K |

n/a

RWOD | $10.61 32.68% 5.1M |

n/a

NVFY | $2.77 31.28% 2.2M |

Consumer Durables

AULT | $0.3174 31.1% 28M |

Manufacturing

WISA 4 | $7.11 20.71% 4.7M |

Electronic Technology

LIFW | News | $0.99 19.26% 800K |

Administrative and Support and ...

PRTG | $0.285 18.75% 140K |

Mining, Quarrying, and Oil and ...

---

Your saved searches

---